Results 31 to 40 of about 35,299 (187)
Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
A patient's refusal to receive blood products can pose both clinical and ethical challenges to the surgeon. In this report, we review the case of a Jehovah's Witness presenting with critical lower limb ischemia and severe anemia for whom the decision of ...
Jeremy D. Kauffman, MD+2 more
doaj +1 more source
THE PLACE FOR SYSTEMIC THROMBOLYSIS IN MODERN REPERFUSION METHODS FOR MYOCARDIAL INFARCTION
The analytic article provides a brief history of thrombolytic therapy in myocardial infarction and discusses benefits and restrictions of contemporary reperfusion methods of treatment.
O. V. Averkov+2 more
doaj +1 more source
Carotid Endarterectomy in the Acute Period of Ischemic Stroke After Thrombolytic Therapy
AIM OF STUDY. To study the outcomes, complications and risk factors of CEA surgery in patients after thrombolytic therapy.MATERIAL AND METHODS. The results of treatment of patients after carotid endarterectomy in the acute period of ischemic acute ...
D. А. Nekrasov+2 more
doaj +1 more source
Does a History of Migraine Affect the Rate of Thrombolysis in Young Stroke Patients?
Background. Migraine is prevalent in young patients and a frequent stroke mimic. To distinguish stroke mimics from true stroke can be difficult, and there is a possibility of misdiagnosing a stroke as a migrainous attack in patients with migraine.
Halvor Øygarden+4 more
doaj +1 more source
Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
Background: The efficacy of thrombolytic therapy for acute ischemic stroke remains controversial in Emergency Medicine and has not been fully endorsed by either the American College of Emergency Physicians or the American Academy of emergency medicine. A
Ryan P Radecki
doaj
Orbital and intracranial hemorrhage following thrombolysis: A case report
Thrombolytic therapy has been a major advance in the treatment of acute myocardial infarction to achieve coronary reperfusion and improve survival. Bleeding is the most common complication following thrombolytic therapy which can occur spontaneously and ...
Karuppannasamy Divya+3 more
doaj +1 more source
This article presents a literature review dedicated to modern methods of noninvasive evaluation of efficacy of thrombolytic therapy in patients with ST-segment elevation in myocardial infarction. D-dimer as a probable marker of myocardial reperfusion and
E. M. Podgornaya+3 more
doaj
Thrombolytic therapy in review
The use of thrombolytic agents for both coronary and noncoronary indications is a rapidly progressing field. There has been substantial debate over which disease processes ultimately benefit from the use of thrombolytic agents. In addition, many recent studies have focused on comparing different thrombolytic agents and dosing regimens in an attempt to ...
Department of Emergency Medicine, East Carolina University School of Medicine/ University Medical Center of Eastern Carolina, Greenville, North Carolina, USA ( host institution )+3 more
openaire +4 more sources
Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods.
L. A. Bondarenko+4 more
doaj +3 more sources
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?
Thrombolysis and primary angioplasty are both recommended reperfusion strategies for elderly patients presenting with myocardial infarction (MI). Primary angioplasty is most beneficial in high-risk patients. While the elderly have a high absolute risk of
White Harvey D
doaj +1 more source